168 related articles for article (PubMed ID: 15897934)
21. Some musculo-skeletal sequelae in cancer survivors.
Aksnes LH; Bruland ØS
Acta Oncol; 2007; 46(4):490-6. PubMed ID: 17497316
[TBL] [Abstract][Full Text] [Related]
22. [Prostate cancer and Cancer Treatment-Induced Bone Loss(CTIBL)].
Matsushima H
Clin Calcium; 2016 Jul; 26(7):1039-45. PubMed ID: 27346316
[TBL] [Abstract][Full Text] [Related]
23. Emerging drugs for the management of cancer treatment induced bone loss.
Bertoldo F; Pancheri S; Zenari S; Boldini S
Expert Opin Emerg Drugs; 2010 Jun; 15(2):323-42. PubMed ID: 20377485
[TBL] [Abstract][Full Text] [Related]
24. Osteoporosis in breast and prostate cancer survivors.
Hoff AO; Gagel RF
Oncology (Williston Park); 2005 Apr; 19(5):651-8. PubMed ID: 15945345
[TBL] [Abstract][Full Text] [Related]
25. Maintaining bone density in patients undergoing treatment for breast cancer: is there an adjuvant benefit?
Gnant M; Dubsky P; Fitzal F; Blaha P; Schoppmann S; Steger G; Marth C; Samonigg H; Hüttner K; Fohler H; Ruecklinger E; Jakesz R; Greil R;
Clin Breast Cancer; 2009 Jun; 9 Suppl 1():S18-27. PubMed ID: 19561003
[TBL] [Abstract][Full Text] [Related]
26. The role of bisphosphonates in the adjuvant setting for breast cancer.
Reeder JG; Brufsky AM
Oncology (Williston Park); 2010 May; 24(6):462-7, 475. PubMed ID: 20568587
[TBL] [Abstract][Full Text] [Related]
27. Cancer Treatment and Bone Health.
Handforth C; D'Oronzo S; Coleman R; Brown J
Calcif Tissue Int; 2018 Feb; 102(2):251-264. PubMed ID: 29353450
[TBL] [Abstract][Full Text] [Related]
28. Breast cancer and osteoporosis - management of cancer treatment-induced bone loss in postmenopausal women with breast cancer.
Kalder M; Hadji P
Breast Care (Basel); 2014 Oct; 9(5):312-7. PubMed ID: 25759610
[TBL] [Abstract][Full Text] [Related]
29. Management of cancer treatment-induced bone loss in early breast and prostate cancer -- a consensus paper of the Belgian Bone Club.
Body JJ; Bergmann P; Boonen S; Boutsen Y; Devogelaer JP; Goemaere S; Reginster JY; Rozenberg S; Kaufman JM
Osteoporos Int; 2007 Nov; 18(11):1439-50. PubMed ID: 17690930
[TBL] [Abstract][Full Text] [Related]
30. Skeletal complications of malignancy.
Coleman RE
Cancer; 1997 Oct; 80(8 Suppl):1588-94. PubMed ID: 9362426
[TBL] [Abstract][Full Text] [Related]
31. Cancer Treatment-Induced Bone Loss in Hormone-Sensitive Cancer: The Paradigm of Cancer Survivor Bone Health Management.
Fortunati N; Gatti F; Felicetti F; Brignardello E
Front Horm Res; 2021; 54():91-102. PubMed ID: 33946075
[TBL] [Abstract][Full Text] [Related]
32. [Bone and calcium metabolism associated with malignancy. Clinical Characteristics and Treatment of Cancer Treatment Induced Bone Loss(CTIBL)in Breast Cancer.].
Taguchi T
Clin Calcium; 2018; 28(11):1515-1517. PubMed ID: 30374009
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic approaches for protecting bone health in patients with breast cancer.
Lüftner D; Niepel D; Steger GG
Breast; 2018 Feb; 37():28-35. PubMed ID: 29073497
[TBL] [Abstract][Full Text] [Related]
34. Understanding and optimizing bone health in breast cancer.
Guise TA; Brufsky A; Coleman RE
Curr Med Res Opin; 2010 Dec; 26 Suppl 3():3-20. PubMed ID: 21050131
[TBL] [Abstract][Full Text] [Related]
35. Cancer treatment-induced bone loss (CTIBL): pathogenesis and clinical implications.
D'Oronzo S; Stucci S; Tucci M; Silvestris F
Cancer Treat Rev; 2015 Nov; 41(9):798-808. PubMed ID: 26410578
[TBL] [Abstract][Full Text] [Related]
36. Awareness, concern, and communication between physicians and patients on bone health in cancer.
Tripathy D; Durie BG; Mautner B; Ferenz KS; Moul JW
Support Care Cancer; 2014 Jun; 22(6):1601-10. PubMed ID: 24477326
[TBL] [Abstract][Full Text] [Related]
37. Osteoporosis and cancer.
Drake MT
Curr Osteoporos Rep; 2013 Sep; 11(3):163-70. PubMed ID: 23877475
[TBL] [Abstract][Full Text] [Related]
38. New generation of bisphosphonates: broad clinical utility in breast and prostate cancer.
Rosen LS
Oncology (Williston Park); 2004 May; 18(5 Suppl 3):26-32. PubMed ID: 15202585
[TBL] [Abstract][Full Text] [Related]
39. [Secondary osteoporosis UPDATE. Pathophysiology and management of cancer treatment-induced bone loss/fractures].
Yoneda T
Clin Calcium; 2010 May; 20(5):690-9. PubMed ID: 20445280
[TBL] [Abstract][Full Text] [Related]
40. Prevention of breast cancer treatment-induced bone loss in premenopausal women treated with zoledronic acid: Final 5-year results from the randomized, double-blind, placebo-controlled ProBONE II trial.
Kyvernitakis I; Kann PH; Thomasius F; Hars O; Hadji P
Bone; 2018 Sep; 114():109-115. PubMed ID: 29908297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
